Last reviewed · How we verify
Sulphonylureas
Sulphonylureas is a Small molecule drug developed by Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders. It is currently FDA-approved.
Sulphonylureas are a class of small molecule organic compounds used in medicine and agriculture. They are characterized by a functional group consisting of a sulfonyl group and a ureylene group, and are the most widely used herbicide.
At a glance
| Generic name | Sulphonylureas |
|---|---|
| Sponsor | Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs
- Pharmacokinetic Study of Single-Dose Modified Release Glipizide in Healthy Volunteers (PHASE1)
- Early Add-On Combination of GLP-1 Receptor Agonist and SGLT2 Inhibitor in People With Cardiovascular-Kidney-Metabolic Stage 2-3
- Effect of Dapagliflozin vs Sitagliptin on Liver Fat Accumulation and Body Composition in Patients With Diabetes Mellitus and Liver Transplantation (NA)
- Oral Anti Diabetic Agents in the Hospital (PHASE4)
- A Pragmatic Randomized Trial to Evaluate the Comparative Effectiveness Between Dapagliflozin and Standard of Care in Type 2 Diabetes Patients (PHASE4)
- Real-world Canadian Retrospective Study Evaluating Longitudinal Semaglutide Use on Cardio-Kidney-Metabolic Outcomes
- Spinal Cord Injury Neuroprotection With Glyburide (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Sulphonylureas CI brief — competitive landscape report
- Sulphonylureas updates RSS · CI watch RSS
- Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders portfolio CI
Frequently asked questions about Sulphonylureas
What is Sulphonylureas?
Who makes Sulphonylureas?
What development phase is Sulphonylureas in?
Related
- Manufacturer: Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing